Literature DB >> 31614212

Genetic diversity of Candida albicans isolates recovered from hospital environments and patients with severe acquired brain injuries.

Fabio Scordino1, Letterio Giuffrè2, Maria Rosa Felice3, Maria Grazia Orlando1, Maria Antonietta Medici3, Francesca Marino Merlo1, Orazio Romeo4.   

Abstract

Although the epidemiology of pathogenic Candida species causing invasive human diseases is changing, Candida albicans still remains the most common cause of bloodstream infections worldwide. The propensity of this pathogen to cause infections is undoubtedly the result of its unique genetic plasticity that allow it to adapt and respond quickly to a myriad of changing conditions both in the host and in the environment. For this reason, we decided to investigate the genetic diversity of this important fungal pathogen in a particular category of patients with severe neurological deficits including the hospital environments where they are hospitalized. Genetic diversity of 21 C. albicans isolates recovered from blood, hands of healthcare workers and hospital environments was evaluated by using multilocus sequence typing (MLST) which revealed a high genetic heterogeneity with a set of 18 diploid sequence types (DSTs) recovered among 21 isolates investigated. Interestingly, 13 of these 18 MLST genotypes were completely new and added to the C. albicans MLST central database. Six eBURST clonal complexes (CC-1, CC-2, CC-6, CC-9, CC-27 and CC-42) and three singletons contained all DSTs found in this study. Among all the new DSTs identified, DST3388 was the most intriguing as this genotype was recovered from a typical C. albicans isolate clustering within the MLST-Clade 13, the most divergent evolutionary lineage within C. albicans population containing only isolates with unusual phenotypes originally known as Candida africana. In conclusion, the results of this study expand our understanding of the molecular epidemiology and global population structure of C. albicans suggesting that further studies on different categories of patients and hospital environments are needed to better understand how the population of this species adapts and evolves in heterogeneous hosts and changing environments.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Candida africana; Candida albicans; Fungal genotyping; Genetic diversity; Multilocus sequence typing (MLST); Neurological patients

Mesh:

Year:  2019        PMID: 31614212     DOI: 10.1016/j.meegid.2019.104068

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  5 in total

1.  Candida africana and Candida dubliniensis as causes of pediatric candiduria: A study using HWP1 gene size polymorphism.

Authors:  Bahram Nikmanesh; Kazem Ahmadikia; Muhammad Ibrahim Getso; Sanaz Aghaei Gharehbolagh; Shima Aboutalebian; Hossein Mirhendi; Shahram Mahmoudi
Journal:  AIMS Microbiol       Date:  2020-08-25

2.  Molecular Diversity and Genetic Relatedness of Candida albicans Isolates from Birds in Hungary.

Authors:  M Domán; L Makrai; Gy Lengyel; R Kovács; L Majoros; K Bányai
Journal:  Mycopathologia       Date:  2021-01-29       Impact factor: 2.574

3.  Network Analysis Guided Designing of Multi-Targeted Anti-Fungal Agents: Synthesis and Biological Evaluation.

Authors:  Manmeet Singh; Himanshu Verma; Priyanka Bhandu; Manoj Kumar; Gera Narendra; Shalki Choudhary; Pankaj Kumar Singh; Om Silakari
Journal:  J Mol Struct       Date:  2022-09-09       Impact factor: 3.841

4.  Distribution, antifungal susceptibility pattern and intra-Candida albicans species complex prevalence of Candida africana: A systematic review and meta-analysis.

Authors:  Sanaz Aghaei Gharehbolagh; Bahareh Fallah; Alireza Izadi; Zeinab Sadeghi Ardestani; Pooneh Malekifar; Andrew M Borman; Shahram Mahmoudi
Journal:  PLoS One       Date:  2020-08-20       Impact factor: 3.240

Review 5.  Plant-Derived Substances in the Fight Against Infections Caused by Candida Species.

Authors:  Ibeth Guevara-Lora; Grazyna Bras; Justyna Karkowska-Kuleta; Miriam González-González; Kinga Ceballos; Wiktoria Sidlo; Maria Rapala-Kozik
Journal:  Int J Mol Sci       Date:  2020-08-25       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.